Format
Sort by

Send to

Choose Destination

Links from MedGen

Items: 1 to 20 of 137

1.

Myotonic dystrophy as a cause of colonic pseudoobstruction: not just another constipated child.

Glaser AM, Johnston JH, Gleason WA, Rhoads JM.

Clin Case Rep. 2015 Jun;3(6):424-6. doi: 10.1002/ccr3.256.

2.

Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis.

Johnson NE, Abbott D, Cannon-Albright LA.

Muscle Nerve. 2015 Oct;52(4):659-61. doi: 10.1002/mus.24766.

3.

Diffuse brain abnormalities in myotonic dystrophy type 1 detected by 3.0 T proton magnetic resonance spectroscopy.

Takado Y, Terajima K, Ohkubo M, Okamoto K, Shimohata T, Nishizawa M, Igarashi H, Nakada T.

Eur Neurol. 2015;73(3-4):247-56. doi: 10.1159/000371575.

PMID:
25824277
4.

Skin features in myotonic dystrophy type 1: an observational study.

Campanati A, Giannoni M, Buratti L, Cagnetti C, Giuliodori K, Ganzetti G, Silvestrini M, Provinciali L, Offidani A.

Neuromuscul Disord. 2015 May;25(5):409-13. doi: 10.1016/j.nmd.2015.02.013.

PMID:
25813338
5.

Myotonic dystrophy and the heart: A systematic review of evaluation and management.

Lau JK, Sy RW, Corbett A, Kritharides L.

Int J Cardiol. 2015 Apr 1;184:600-8. doi: 10.1016/j.ijcard.2015.03.069. Review.

PMID:
25769007
6.

Anticipation in myotonic dystrophy type 1 parents with small CTG expansions.

Pratte A, Prévost C, Puymirat J, Mathieu J.

Am J Med Genet A. 2015 Apr;167A(4):708-14. doi: 10.1002/ajmg.a.36950.

PMID:
25712547
7.

Long-term arrhythmia follow-up of patients with myotonic dystrophy.

Benhayon D, Lugo R, Patel R, Carballeira L, Elman L, Cooper JM.

J Cardiovasc Electrophysiol. 2015 Mar;26(3):305-10. doi: 10.1111/jce.12604.

PMID:
25546341
8.

Prevalence of muscular dystrophies: a systematic literature review.

Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V.

Neuroepidemiology. 2014;43(3-4):259-68. doi: 10.1159/000369343. Review.

9.

Psychological characteristics of patients with myotonic dystrophy type 1.

Bertrand JA, Jean S, Laberge L, Gagnon C, Mathieu J, Gagnon JF, Richer L.

Acta Neurol Scand. 2015 Jul;132(1):49-58. doi: 10.1111/ane.12356.

PMID:
25496310
10.

Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.

Zampetti A, Silvestri G, Manco S, Khamis K, Masciullo M, Bianchi ML, Damiani A, Santoro M, Linder D, Bewley A, Feliciani C.

J Am Acad Dermatol. 2015 Jan;72(1):85-91. doi: 10.1016/j.jaad.2014.09.038.

PMID:
25440959
11.

Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Jean S, Richer L, Laberge L, Mathieu J.

Orphanet J Rare Dis. 2014 Nov 26;9:186. doi: 10.1186/s13023-014-0186-5.

12.

Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Bouchard JP, Cossette L, Bassez G, Puymirat J.

J Neurol. 2015 Feb;262(2):285-93. doi: 10.1007/s00415-014-7570-x.

PMID:
25380585
13.

Myotonic dystrophy: diagnosis, management and new therapies.

Turner C, Hilton-Jones D.

Curr Opin Neurol. 2014 Oct;27(5):599-606. doi: 10.1097/WCO.0000000000000128. Review.

PMID:
25121518
14.

Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage.

Caso F, Agosta F, Peric S, Rakočević-Stojanović V, Copetti M, Kostic VS, Filippi M.

PLoS One. 2014 Aug 12;9(8):e104697. doi: 10.1371/journal.pone.0104697.

15.

Myotonic dystrophy.

Thornton CA.

Neurol Clin. 2014 Aug;32(3):705-19, viii. doi: 10.1016/j.ncl.2014.04.011. Review.

16.

Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.

Meola G, Cardani R.

Biochim Biophys Acta. 2015 Apr;1852(4):594-606. doi: 10.1016/j.bbadis.2014.05.019. Review.

17.

Risk of cancer in relatives of patients with myotonic dystrophy: a population-based cohort study.

Lund M, Diaz LJ, Gørtz S, Feenstra B, Duno M, Juncker I, Eiberg H, Vissing J, Wohlfahrt J, Melbye M.

Eur J Neurol. 2014 Sep;21(9):1192-7. doi: 10.1111/ene.12466.

PMID:
24838088
18.

Cardiac manifestations in myotonic dystrophy type 1 patients followed using a standard protocol in a specialized unit.

Facenda-Lorenzo M, Hernández-Afonso J, Rodríguez-Esteban M, de León-Hernández JC, Grillo-Pérez JJ.

Rev Esp Cardiol (Engl Ed). 2013 Mar;66(3):193-7. doi: 10.1016/j.rec.2012.08.011.

PMID:
24775453
19.

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.

Carpentier C, Ghanem D, Fernandez-Gomez FJ, Jumeau F, Philippe JV, Freyermuth F, Labudeck A, Eddarkaoui S, Dhaenens CM, Holt I, Behm-Ansmant I, Marmier-Gourrier N, Branlant C, Charlet-Berguerand N, Marie J, Schraen-Maschke S, Buée L, Sergeant N, Caillet-Boudin ML.

Biochim Biophys Acta. 2014 Apr;1842(4):654-64. doi: 10.1016/j.bbadis.2014.01.004.

20.

Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Caillet-Boudin ML, Fernandez-Gomez FJ, Tran H, Dhaenens CM, Buee L, Sergeant N.

Front Mol Neurosci. 2014 Jan 9;6:57. doi: 10.3389/fnmol.2013.00057. Review.

Items per page

Supplemental Content

Support Center